19 Dec UW–Madison’s next chapter
New chancellor Jennifer L. Mnookin crafts a "collective vision" for the university's future....
New chancellor Jennifer L. Mnookin crafts a "collective vision" for the university's future....
Research programs and studies that are built on a DEI foundation will inevitably have a positive influence on the trajectory of goals that include increasing diversity in clinical trials and cultivating inclusive environments for the biomedical research workforce....
The University of Wisconsin–Madison ranks eighth in national research rankings for public and private universities and increased research expenditures across all fields....
Predictions for how clinical trials will evolve to better serve patients in 2023 and beyond....
A strong shift to decentralized clinical trials, regulatory changes, and an increased focus on diversity were among the main industry talking points in 2022....
The promising performance of an experimental HIV vaccine may lead to an effective vaccine strategy for HIV and AIDS....
Tina Graber discusses her career path and current role as Operations Manager for the regulatory service line within the UW Clinical Research Office (CRO)....
Disease and Bernard Coley are utilizing Denise's Parkinson's disease diagnosis as a platform to inform communities of color about the importance of engaging in clinical trials....
As the tolerance bar for excluding clinical trials participants on the grounds of race and sex lowers significantly, exclusion based on cognitive disability still goes on....
Children who participate in clinical trials can help provide researchers with information adults cannot....